Chronic prurigo revealing an angioimmunoblastic T cell lymphoma

Tunisie Medicale

Volumn 87, Issue 8, 2009, Pages 543-546

  Khaled, Aida ^a   Sfia, Mehdi ^a   Fazaa, Becima ^a   Kourda, Nadia ^a   Zermani, Rachida ^a   Baccouche, Kamel ^a   Jilani, Sara Ben ^a   Kamoun, Mohamed Ridha ^a  

^a NONE

Author keywords

An angio immunoblastic T cell lymphoma; Chronic prurigo

Indexed keywords

CD30 ANTIGEN; VIRUS PROTEIN;

ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FEVER; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MACULOPAPULAR RASH; MALE; PAPULAR URTICARIA; SPLENOMEGALY; SWEATING; T CELL LYMPHOMA; WEIGHT REDUCTION;

EID: 77649258827     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Aractingi S, Mansouri S. Manifestations cutanées associées aux hémopathies malignes. Press med 1997; 26: 678-83.
2. Martel P et al. Cutaneous involvement in patients with Angioimmunobastic lymphadenopathy with dysproteinemia. A clinical, immunohistological and Molecular analysis. Arch Dermatol 2000; 136: 881-6.
3. Jayaraman AG, Cassarino D, Advani R, Kim YH, Tsai E, Kohler S. Cutaneous involvement by Angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. J Cutan Pathol 2006; 33: 6-11.
4. Greer JP, Therapy of peripheral T/NK neoplasms. Hematology Am Soc Hematol Educ Program. 2006:331-7. Review.
5. Bernstein JE, Soltani K, Lorienz AL. Cutaneous manifestations of angioimmunoblastic lymphadenopathy: J Am Acad Dermatol 1979; 1: 227-32.
6. Maltoff RB, Neimann RS. Angioimmunoblastic lymhadenopathy: A generalized lymphoproliferative disorder with cutaneous manifestations. Arch dermatol 1978; 114: 92-94.
7. Murakami T, Ohtsuki M, Hakagawa H. Angioimmunoblastic lymphadenopathy-type T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile. Br J Dermatol 2001; 144: 878-84.
8. Yoon GS, Chang SE, Kim HH, Choi JH, Sung KJ, Moon KC. Cutaneous relapse of angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma mimicking an exanthematous drug eruption: a unique histologic presentation, mimicking an infectious etiology. Int J Dermatol 2003; 42: 816-8.
9. Wechsler HL, stavrides A. Immunoblastic lymphadenopathy with purpura and cryoglobulinemia. Arch Dermatol 1977; 113: 636-41
10. Kluin-Neleman HC, Elbers HR, Ramselaar CG. Angioimmunoblastic lymphadenopathy followed by Kaposi's sarcoma. Arch Dermatol 1983; 120: 958-9.
11. Helm TN, Steck WD, Proffitt MR, Bergfeld WF, Tubbs RR, Lo J. Kaposi's sarcoma, angioimmunoblastic lymphadenopathy, and antibody to HIV-1 p24 antigen in a patient nonreactive for HIV-1 with use of ELISA. J Am Acad Dermatol. 1990; 23: 317-8.
12. Mihaljevic B et al. Angioblastic lymphadenopathy-its course and prognosis. Srp Arch Celok Lek. 1999;127: 376-82.
13. Schmuth M et Al. Cutaneous involvement by Angioimmunoblastic lymphadenopathy. J Am Acad Dermatol 1997; 36: 290-5.
14. Jones D et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000; 96: 685-90.
15. Attygalle A et Al. Neoplastic T cells in angioimmunobalstic t-cell lymphoma express CD10. Blood 2002; 99: 627-33.
16. Schlegelberger B, et al. Significance of cytogenetic finding for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphoadenopathy type. J Clin Oncol 1996; 14: 593-9.
17. Siegert W et al. Angioimmunoblastic lymphadenopathy (AILD)- type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol 1995; 6:659-64.
18. Went P et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol.2006; 24:2472-9
19. Smith JL, Hodges E, Quin TC, McCarthy KP, Wright DH. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000; 156: 661-64.